QCG
NUTX

Quadrant Capital Group’s Nutex Health NUTX Stock Holding History

Quadrant Capital Group’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$191 Buy
+2
New +$245 ﹤0.01% 2668

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Quadrant Capital Group's NUTX Position: Q1 2026 in Review

Quadrant Capital Group opened a new position in Nutex Health (NUTX) in Q1 2026: 2 shares worth $191. The stake represents ﹤0.01% of the portfolio and ranks #2668 among its holdings.

129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Quadrant Capital Group held 2 shares of Nutex Health worth $191 as of Q1 2026.
  • Nutex Health was a new Quadrant Capital Group position in Q1 2026.
  • Nutex Health made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2668 holding.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.